-
Samsung Bioepis forms new alliance to expand in China
pharmaceutical-technology
February 13, 2019
Samsung Bioepis has signed a licensing deal with healthcare-focused private equity firm C-Bridge Capital to accelerate expansion in mainland China....
-
Sandoz selects finalists in digital tech healthcare access competition
pharmaphorum
January 17, 2019
Sandoz has selected three finalists in a competition to use digital technology to increase access to medicines in poorer countries.
-
Mental health services falling behind rest of NHS – report
pharmaphorum
January 15, 2019
Mental health services in the UK are falling behind physical health services because of outdated commissioning services in the National Health Service, according to a new report.
-
EPA Streamlines Hazardous Waste Pharmaceuticals Regulations
americanpharmaceuticalreview
January 14, 2019
U.S. Environmental Protection Agency (EPA) Acting Administrator Andrew Wheeler signed a final rule streamlining standards for managing hazardous waste pharmaceuticals in the healthcare sector.....
-
2018 set benchmark for digital health investment – report
pharmaphorum
January 09, 2019
Last year was the biggest ever for digital health investment, according to a report that has been tracking the market since the beginning of the decade.
-
GE Healthcare files confidential IPO listing: report
fiercebiotech
December 25, 2018
General Electric has submitted a confidential filing to spin out its healthcare business into a publicly traded company, with an IPO likely taking place early next year, according to a report from Bloomberg....
-
GlaxoSmithKline, Pfizer to Form New Consumer Healthcare Joint Venture
americanpharmaceuticalreview
December 21, 2018
GlaxoSmithKline has reached agreement with Pfizer to combine their consumer health businesses into a new Joint Venture, with combined sales of approximately $12.7 billion.....
-
GSK and Pfizer to create $13bn consumer healthcare joint venture
pharmaceutical-technology
December 20, 2018
GlaxoSmithKline (GSK) and Pfizer have agreed to merge their consumer health businesses to create a new joint venture with an estimated £9.8bn ($12.7bn) in annual sales.....
-
Novartis considers reinsurance model to fund next generation therapies
pharmaceutical-technology
December 18, 2018
Novartis has announced it is looking into working with reinsurers as a way to help healthcare providers fund the ultra-high cost of new personalised therapies......
-
Lonza to Establish Strategic Biomanufacturing Base in China Using GE Healthcare Solution
americanpharmaceuticalreview
December 11, 2018
Lonza announced an agreement with GE Healthcare under which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou (CN). As the facility is part of a larger....